新春伊始，万象更新。年味尚未散尽，连云港市海州区各大重点项目建设现场已是一片热火朝天的繁忙景象，全区复工复产工作全面提速。机械轰鸣作 响，工程车辆往来穿梭，建设者们迅速从"春节模式"切换至"奋斗模式"，以时不我待、真抓实干的劲头抢工期、赶进度、保质量，在全区掀起项目建设新 热潮，为新年高质量发展开好局、起好步。 通讯员赵威娜刘雪明黄新茹郑娜扬子晚报/紫牛新闻记者张凌飞 校对朱亚萍 产业项目建设现场同样涌动着奋进的热潮，成为海州培育新质生产力的生动实践。百川医疗器械半成品制造项目工地，桩机正加紧打桩，桩基施工按计划 有序推进，项目施工许可证已办理完毕，为后续全面开工筑牢合规基础。该项目总投资2.2亿元，新建2万平方米厂房，投产后将年产血氧仪、血压计各 2000台，填补区域医疗器械半成品制造领域空白。同合电器智能电器柜检测车间项目现场亦是一派忙碌，桩基施工稳步开展，807平方米的检测车间建成 后将配备激光焊机、各类专业检测仪器，大幅提升企业生产和检测效率。 黄海勘探年产1800台套钻探设备项目建设则进入收尾攻坚阶段，办公楼消防照明系统安装完毕等待验收，铆焊车间、油漆喷砂间正进行固化地坪施工。该 项目占地116.7 ...

Industry Overview - The ear thermometer is a non-contact temperature measurement tool that offers advantages such as accuracy, speed, convenience, safety, and resistance to external environmental interference, making it suitable for various applications in healthcare, industry, schools, homes, and public places [1][12] - The market demand for ear thermometers has been steadily increasing, particularly influenced by heightened public health awareness and advancements in medical detection technology [1][12] - In 2020, the domestic ear thermometer market size exceeded 600 million yuan, with a year-on-year growth of 17.31%, highlighting its critical role in public health emergency systems [1][12] - The market size for the ear thermometer industry in China is projected to reach 830 million yuan in 2024, with a year-on-year growth of 6.41%, and approximately 900 million yuan in 2025 [1][12] Industry Development History - The ear thermometer industry traces back to the 1980s, gaining momentum in the 1990s due to rising household demand for medical devices [7] - The 21st century has seen unprecedented growth in the ear thermometer industry, driven by continuous innovation in medical technology and increased public health awareness [7] Industry Chain - The ear thermometer industry chain consists of upstream raw materials and components, including metals, plastics, infrared sensors, chips, displays, batteries, and microcontrollers [8] - The midstream involves the production and manufacturing of ear thermometers, while the downstream encompasses sales channels such as medical device specialty stores, large chain pharmacies, e-commerce platforms, and supermarkets [8] Market Competition - The competition in the ear thermometer industry features both domestic and international brands, with foreign companies holding significant market positions due to their established technology and brand advantages [13] - Notable domestic companies include Yuyue Medical, Jiuan Medical, and Kefu Medical, which are rapidly developing through product innovation and channel expansion [13] Key Companies - Yuyue Medical Equipment Co., Ltd. focuses on providing home medical devices and clinical products, with a significant portion of its revenue coming from home health monitoring solutions [13] - Kefu Medical Technology Co., Ltd. specializes in medical device research, production, and sales, with a diverse product line covering health monitoring and rehabilitation [14] Future Trends - The ear thermometer is expected to evolve into a personal health management terminal that integrates health data monitoring and intelligent analysis, enhancing its role in chronic disease management and early epidemic screening [15] - Continuous improvements in measurement accuracy will focus on overcoming complexities in deep ear canal measurements through multi-sensor fusion technology and adaptive calibration algorithms [16] - The industry is anticipated to shift towards data and service-oriented ecological integration, establishing new standards for measurement accuracy and data privacy, which will enhance the reliability of temperature data for remote healthcare and public health monitoring [18]

据悉，银发商店定位为"一站式银龄生活服务生态"体验场，划分九大功能区域，融合产品展示、实景体 验、健康检测、服务咨询、社交娱乐及直播互动等多种服务，旨在让老年人亲身感受未来居家生活的可 能性。 本报讯（记者夏骅）昨天，北京长城银发商店在金隅天坛家居MALL亮相，约500平方米的店内，陈列 着超过300款适老化产品。 在"天坛局装"适老化样板间里，工作人员正为参观老人详细介绍浴室一体化方案："洗漱台面和镜子都 能自动调节高度，马桶和浴室也全部采用适老化设计。"记者注意到，洗漱台下方设有升降按钮，可整 体移动，方便坐轮椅的老人照镜子。马桶同样支持升降与位置调节，能根据老人实际需要灵活调整。 店内还集中展示了血氧仪、血压计等健康监测设备，以及多款电动轮椅和适老化家具。其中，一款智能 防摔马甲颇受关注。黑色马甲外观轻便，其内置的AI算法能区分摔倒与日常弯腰动作，并在跌倒瞬间 迅速弹开气囊提供保护。 店内的智能机器人在与参观者互 动。本报记者武亦彬 摄 ...

- The report introduces a "Total Heat Index" indicator, defined as the sum of browsing, self-selection, and click counts for individual stocks, normalized by their market share on the same day, and multiplied by 10,000. The indicator range is [0,10000][7] - A rotation strategy is constructed based on the weekly heat index change rate (MA2). At the end of each week, the strategy buys the broad-based index with the highest MA2 change rate. If the "Others" group has the highest change rate, the strategy remains in cash. The annualized return since 2017 is 8.74%, with a maximum drawdown of 23.5%. In 2026, the strategy achieved a return of 7.9%[13][16] - A concept-based strategy is developed by selecting the top 5 concepts with the highest weekly heat index change rate. Stocks within these concepts are filtered by excluding the bottom 20% in terms of market capitalization. Two portfolios are constructed: the "TOP" portfolio holds the top 10 stocks with the highest heat index within each concept, while the "BOTTOM" portfolio holds the bottom 10 stocks. The "BOTTOM" portfolio historically achieved an annualized return of 15.71% with a maximum drawdown of 28.89%. In 2026, the "BOTTOM" portfolio returned 6.4%[32][34]

Market Overview - The Shanghai Composite Index has returned to above 4000 points, marking a twelve-day winning streak, with a closing increase of 1.38% [1][6] - The Shenzhen Component Index rose by 2.24%, while the ChiNext Index led the gains with a 2.85% increase [2][6] Sector Performance - The top-performing sectors included Media (4.12%), Pharmaceuticals (3.85%), Electronics (3.69%), Non-Bank Financials (3.14%), and Computers (2.71%) [3] - Conversely, the worst-performing sectors were Oil & Petrochemicals (-1.29%), Banks (-0.34%), Transportation (-0.30%), Retail (-0.17%), and Agriculture, Forestry, Animal Husbandry, and Fishery (0.00%) [3] Conceptual Sector Highlights - The leading conceptual sectors were Brain-Computer Interface (13.70%), Hyperbaric Oxygen Chamber (7.01%), Blood Oxygen Monitor (5.65%), and New Technology Stocks (5.19%) [3] - The lagging conceptual sectors included Hainan Free Trade Zone (-2.93%), Duty-Free Shops (-1.08%), Free Trade Ports (-0.94%), Pork (-0.28%), and Ride-Hailing (-0.05%) [3] Future Outlook - The market opened strong on the first trading day of 2026, with significant participation from over 4100 stocks rising, including 127 hitting the daily limit [6] - The manufacturing PMI showed a seasonal rebound, indicating improved supply and demand, while the construction PMI saw a significant month-on-month increase, suggesting a potential boost to the economy [6] - The report anticipates continued market liquidity and risk appetite improvement, supported by favorable domestic policies and a strengthening RMB, with a focus on sectors such as TMT, Finance, Machinery, Military, Power, and Nonferrous Metals for investment opportunities [6]

Group 1 - The blood oxygen monitor concept sector rose by 5.65%, ranking third among concept sectors, with 24 stocks increasing, including Aipeng Medical and Lepu Medical reaching a 20% limit up [1] - The top gainers in the blood oxygen monitor sector included Jiahe Intelligent, Kefu Medical, and Libang Instruments, which rose by 13.18%, 11.10%, and 7.82% respectively [1] - The blood oxygen monitor sector saw a net inflow of 943 million yuan from main funds, with 15 stocks receiving net inflows, and 7 stocks exceeding 10 million yuan in net inflow [1] Group 2 - The leading stocks in terms of net inflow ratio included Aipeng Medical, Lepu Medical, and Hongri Pharmaceutical, with net inflow ratios of 25.43%, 18.55%, and 14.65% respectively [2] - The top stocks by main fund flow in the blood oxygen monitor sector included Lepu Medical with a net inflow of 485 million yuan, followed by Sichuan Changhong and Aipeng Medical with net inflows of 195 million yuan and 156 million yuan respectively [2] - The trading performance of various stocks showed significant fluctuations, with some stocks like Aipeng Medical and Lepu Medical achieving notable gains and high turnover rates [3]

Core Insights - The blood oxygen monitor industry in China is experiencing strong growth driven by the increasing prevalence of chronic respiratory and cardiovascular diseases, particularly due to the aging population, which has led to a significant rise in demand for long-term blood oxygen monitoring [1][9] - The market size of the blood oxygen monitor industry in China is projected to grow from 3.8 billion yuan in 2019 to 4.5 billion yuan in 2024, with a compound annual growth rate (CAGR) of 3.44%. By 2030, the market size is expected to exceed 8 billion yuan, indicating a promising future for the industry [1][9] - The rapid adoption of telemedicine and the general increase in public health awareness are facilitating the transition of blood oxygen monitors from professional medical settings to home care and chronic disease management [1][9] Industry Overview - Blood oxygen monitors are medical devices used to measure vital indicators such as blood oxygen saturation and heart rate, with common types including fingertip, wrist, tabletop, handheld, and wearable monitors [3] - The industry has evolved significantly since the mid-1990s, transitioning from professional medical use to home and mobile applications, with advancements in technology enabling features like data collection and remote monitoring [3] Industry Policies - Blood oxygen monitors are classified as Class II medical devices under the Medical Device Supervision and Administration Regulations, requiring strict management to ensure safety and effectiveness [4] - Recent government policies aim to enhance the development of the blood oxygen monitor industry, including measures for intellectual property protection and subsidies for consumers purchasing medical devices [4] Market Dynamics - The aging population in China is a key driver for the demand for blood oxygen monitors, with the number of individuals aged 60 and above expected to reach 31.03 million by the end of 2024, accounting for 22% of the total population [5] - The blood oxygen monitor industry is supported by a robust supply chain, including raw materials, manufacturing, and sales channels, with both online and offline distribution methods [5][6] Competitive Landscape - The global blood oxygen monitor market is characterized by a mix of established international players and emerging domestic brands, with companies like Masimo Corporation and Philips leading in high-end medical-grade monitors [10][11] - Chinese companies such as Yuyue Medical and Kangtai Medical are gaining market share by offering competitive products in the mid to low-end segments, with a focus on quality and performance [10][11] Future Trends - The blood oxygen monitor industry is expected to see advancements in smart technology, enabling continuous data collection and personalized health management [14] - The trend towards portability will drive the development of smaller, lighter devices that integrate with wearable technology, enhancing user convenience [15] - The application scenarios for blood oxygen monitors are expanding beyond traditional medical settings to include fitness, high-altitude travel, and workplace health management [16]

Core Viewpoint - The issuance of the technology innovation bonds by Jiuan Medical was successful, achieving an AAA credit rating and a 1.83% issuance interest rate, with an initial issuance scale of 1.05 billion yuan, reflecting market trust and recognition of the company's development [1]. Group 1: Company Overview - Jiuan Medical is primarily known for producing common household health monitoring devices such as thermometers, blood pressure monitors, and pulse oximeters, but it has diversified into home medical health products, internet healthcare, and technology investment [1]. - The company plans to invest approximately 270 million yuan in research and development in 2024, focusing on projects like continuous glucose monitoring (CGM) and AIoT diabetes home assistance [1]. Group 2: Bond Issuance Process - The company faced initial challenges in the bond issuance process, particularly regarding credit rating, but successfully communicated with rating agencies to demonstrate asset quality and financial health, ultimately achieving an AAA rating [2][3]. - The technology innovation bonds are designed to meet the financing needs of technology companies, allowing funds to be used for R&D, direct investments, and fund contributions, thereby enhancing capital turnover efficiency and reducing overall financing costs [2]. Group 3: Market Context and Challenges - Jiuan Medical's financial indicators met the requirements for issuing technology innovation bonds, and its intellectual property, including FDA approval, was considered a significant asset in the evaluation process [3]. - The company expressed concerns about the bond market's unfamiliarity, including questions about the efficiency of the issuance process and the potential for successful fundraising, which were addressed in a policy briefing organized by the China Interbank Market Dealers Association [3]. Group 4: Industry Implications - The issuance of technology innovation bonds is expected to inject new momentum into Jiuan Medical and its associated funds, accelerating the transformation of quality projects and technological achievements [4]. - The current challenge for many technology innovation companies is their asset-light operating model, which often lacks public market ratings, limiting support from traditional financing channels [4][5].

Core Viewpoint - Yuyue Medical is facing significant challenges in achieving its ambitious five-year targets of 10 billion in revenue and 100 billion in market value, as evidenced by its latest financial report showing a decline in net profit despite revenue growth [1] Group 1: Financial Performance - In the first three quarters of 2025, Yuyue Medical reported revenue of 6.545 billion, an increase of 8.58% year-on-year, but net profit decreased by 4.28% to 1.466 billion [1] - The third quarter saw a dramatic 36% year-on-year drop in net profit, indicating a "revenue without profit" situation [1] Group 2: Expansion Aftermath - Since its listing in 2008, Yuyue Medical has engaged in numerous acquisitions, resulting in a significant increase in goodwill from 806 million in 2020 to 1.107 billion in 2023, with a slight decrease expected in 2024 [2] - The company has faced nearly 100 million in goodwill and credit impairment losses in 2023 and 2024 [2] - Sales expenses surged to 1.233 billion in the first three quarters of 2025, a 33.15% increase year-on-year, significantly outpacing revenue growth [2] Group 3: Industry Competition and Trust Issues - The home medical device sector is experiencing intensified price competition, with foreign brands penetrating the mid-to-low-end market and domestic companies accelerating technological advancements [3] - Yuyue Medical has faced compliance issues, including a 2.7 million fine for price gouging during the pandemic and the loss of a military procurement pre-bid qualification due to violations [3] - Customer complaints regarding product quality and service have exceeded 500, damaging the brand's reputation [3] Group 4: Transformation Efforts - To address growth challenges, Yuyue Medical is focusing on transformation by increasing investment in new products and integrating AI into its offerings [4] - Despite these efforts, the company's net profit excluding non-recurring items fell by 8.21% year-on-year in the first three quarters of 2025, indicating ongoing weakness in core business profitability [4] - Government subsidies and investment income have become crucial for supporting profits, highlighting the sluggish growth of the main business [4] Conclusion - Yuyue Medical's ambitious targets appear increasingly distant due to accumulated goodwill risks, rising sales expenses, fierce industry competition, and frequent compliance disputes [5] - The success of AI and new products as potential solutions will depend on the company's ability to balance profitability, product trust, and strategic execution [5]

Core Viewpoint - Yuyue Medical has a diverse range of products, including influenza virus antigen detection kits, which are currently available for sale [2] Product Range - The company offers a variety of medical devices such as nebulizers, pulse oximeters, disinfection and infection control products, and temperature monitoring devices [2] - These products can be utilized in home health management solutions for diseases including, but not limited to, influenza [2] Usage Guidance - Patients are advised to use medical devices in accordance with medical advice [2]